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An integrated study of the aﬃnities of the Ab16
peptide for Cu(I) and Cu(II): implications for the
catalytic production of reactive oxygen species†
Tessa R. Young,ab Angie Kirchner,‡ab Anthony G. Weddab and Zhiguang Xiao*ab
A new fluorescent probe Ab16wwa based upon the Ab16 peptide has been developed with two orders
of magnitude greater fluorescence intensity for sensitive detection of interactions with Cu(II). In combina-
tion with the Cu(I) probe Ferene S, it is confirmed that the Ab16 peptide binds either Cu(I) or Cu(II) with
comparable aﬃnities at pH 7.4 (logK ID = 10.4; logK IID = 10.0). It follows from this property that the Cu–Ab16
complex is a robust if slow catalyst for the aerial oxidation of ascorbate with H2O2 as primary product (initial
rate, B0.63 min1 for Cu–Ab16 versus >2.5 min1 for Cuaq
2+). An integrated study of variants of this peptide
identifies the major ligands and binding modes involved in its copper complexes in solution. The dependence
of K ID upon pH is consistent with a two-coordinate Cu(I) site in which dynamic processes exchange Cu(I)
between the three available pairs of imidazole sidechains provided by His6, His13 and His14. The N-terminal
amine is not involved in Cu(I) binding but is a key ligand for Cu(II). Acetylation of the N-terminus alters the
redox thermodynamic gradient for the Cu centre and suppresses its catalytic activity considerably. The data
indicate the presence of dynamic processes that exchange Cu(II) between the three His ligands and back-
bone amide at physiological pH. His6 is identified as a key ligand for catalysis as its presence minimises the
pre-organisation energy required for interchange of the two copper redox sites. These new thermodynamic
data strengthen structural interpretations for the Cu–Ab complexes and provide valuable insights into the
molecular mechanism by which copper chemistry may induce oxidative stress in Alzheimer’s disease.
Introduction
While the underlying molecular causes of Alzheimer’s disease
remain unknown, mis-handling of the Ab peptides derived
from the amyloid precursor protein during recycling may be
an initiating event (‘the amyloid cascade’).1–4 Aberrant metal
ion homeostasis appears to contribute by promoting aggrega-
tion of the peptides and/or inducing toxic gain of function.5–7
In this context, the potential role of the trace metal copper has
been emphasised (see ref. 8 for a review).
The aﬃnity of Ab peptides for Cu(II) remains a topic of discussion
(see recent reviews9,10) although a consensus of KDB 10
10M is buil-
ding.11–13 On the other hand, the affinity for Cu(I) remains proble-
matical.14,15 Spectroscopic data have provided extensive information
on the structure of Cu–Ab complexes and of those of the truncated
form Ab16(DAEFRHDSGYEVHHQK), in particular. This fragment
appears to provide the copper binding sites of highest affinity. The
twomajor coordination forms of monomeric CuII–Ab are related by a
pKa B 7.8,
16–22 while a single dominant Cu(I) form has been
characterised spectroscopically.23,24 Rapid ligand exchange processes
have been detected.21,25 The ability of these complexes to catalyse the
production of H2O2 by reduction of O2 by ascorbate (Asc) has been
explored as amodel for the production of reactive oxygen species that
may be primarily responsible for inflammation responses.
The present work defines the dissociation constants of both Cu(I)
and Cu(II) for the peptide Ab16 under the same conditions using
chromophoric and fluorescence probes of appropriate aﬃnities. A
new probe for Cu(II) has been developed from the Ab16 peptide itself
while those for Cu(I) were defined in recent work.26 Application to
variant forms of the Ab16 peptide has correlated the new thermo-
dynamic data with existing spectroscopic structural data while the
ability of the Cu complexes of the peptide and its variants to catalyse
production of reactive oxygen species is explored.
Experimental section
Materials and general methods
Materials purchased from Sigma included ligands Ferene S (Fs)
and Ferrozine (Fz) (as their sodium salts Na2Fs and NaHFz),
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reductants NH2OH (as its H2SO4 salt) and ascorbic acid, a
copper standard (as a standard solution for calibration of
atomic absorption spectroscopy), Amplex Red (also called
Ampliflu Red) and horseradish peroxidase (HRP). They
were all used as received. Proteins CopK and its variant
CopK-H70F were expressed and isolated as reported previously.27
Peptides Ab16 (sequence: DAEFRHDSGYEVHHQK), Ac-Ab16
(Ac-DAEFRHDSGYEVHHQK); Ab16-H13A (DAEFRHDSGYEVAHQK),
Ab16-H6,13A (DAEFRADSGYEVAHQK); Ab16-H13,14A (DAEFRHDS
GYEVAAQK) were purchased from GL Biochem (Shanghai) with
purity estimated at >98%. Peptides Ab16-F4W,Y10W,H14A (denoted
as Ab16wwa, DAEWRHDSGWEVHAQK); Ab16-H6A (DAEFRADS
GYEVHHQK) and Ab16-H14A (DAEFRHDSGYEVHAQK) were synthe-
sised on site by solid phase peptide techniques. Identity was verified
by electrospray ionisation mass spectrometry (ESI-MS) while purity
was confirmed to be >98% by HPLC. Peptide concentrations were
estimated from absorbance maxima at B276 nm using emax =
1410 M1 cm1 for those Ab16 peptides containing a single tyrosine
residue and using e = 11000 M1 cm1 at 280 nm for the Ab16wwa
probe peptide containing two tryptophan residues. The concentra-
tions obtainedmatched those estimated from fluorescence titrations
with the copper standard assuming formation of a 1 :1 complex.
All ligand stock solutions, reaction buﬀers, reductant solutions
and protein solutions were prepared in rigorously deoxygenated
Milli-Q water and stored in an anaerobic glove-box (o1 ppm O2).
The working solution of ligand Fs was prepared freshly from
aliquots of frozen stock solution stored in a freezer at temperature
80 1C.26 All reactions involving Cu(I) were performed anaero-
bically in the glove-box and transported outside in a capped
cuvette for spectroscopic characterisation.
UV-Vis and fluorescence titration
UV-visible spectra were recorded on a Varian Cary 300 spectro-
photometer in dual beam mode with quartz cuvettes of 1.0 cm
path length. All metal titrations were performed in appropriate
buﬀers and corrected for baseline and dilution. Fluorescence
emission spectra were obtained on a Varian Cary Eclipse
spectrophotometer. The excitation wavelength was 280 nm with
a band pass of 20 nm for both excitation and emission spectra.
Spectra were recorded between 290–600 nm at a scale rate of
600 nm min1. The absorbance of solutions was maintained
below A280 = 0.1 to minimise resorption effects.
Quantification of Cu(I) binding
Data of K ID for proteins and peptides P were obtained from the
competition reaction of eqn (1) and analysed by eqn (2):26
CuIL2
 3 þ PÐ CuIPþ 2L2 ðL ¼ Fs or FzÞ (1)
½Ptot
½Cutot
¼ 1 Cu
IL2
 
½Cutot
þ KDb2
½Ltot
CuIL2
  2
 !2
CuIL2
 
1 Cu
IL2
 
½Cutot
 !
(2)
The term [CuIL2] is the equilibrium concentration of probe
complex [CuIL2]
3 in eqn (1) and may be determined directly
from the solution absorbance under the condition that this
complex is the only absorbing species. The other terms in
eqn (2) are the known total concentrations of the relevant
species. The dissociation constant K ID for Cu
I–P was derived by
curve-fitting of the experimental data to eqn (2) (i.e., plots of
[P]tot/[Cu]tot versus [Cu
IL2]) with b2 = 10
13.7 and 1015.1 M2 for
L = Fs and Fz, respectively.26 The detailed experimental pro-
tocol followed that reported recently.26 The experiments
were conducted anaerobically in deoxygenated MOPS buffer
(50 mM, pH 7.4) containing reductants NH2OH (0.5 mM) and/
or Asc (0.5 mM) (denoted as buffer A) in a glovebox ([O2] o
1 ppm). The samples were transferred in sealed containers for
characterisation.
The sidechains of the three histidine residues (His-6,13,14)
in Ab16 peptides are likely to be involved in Cu(I) binding. Their
pKa values in an Ab28 peptide have been estimated to be 6.5, 6.6
and 6.5, respectively.28 Consequently, the apparent dissociation
constants K I
0
D for Cu(I) binding are likely to be sensitive to pH
around pH 6.5. A quantitative analysis of the relationship
between KI
0
D and solution pH should provide information about
the number of His residues being involved in the Cu(I) binding.
For two- and three-His binding models, the relationship may be
described by eqn (3) and (4), respectively:29
K I
0
D ¼ KID 1þ 10pKapH þ 102pKa2pH
 
(3)
K I
0
D ¼ KID 1þ 10pKapH þ 102pKa2pH þ 103pKa3pH
 
(4)
where KI
0
D and K
I
D refer, respectively, to pH-dependent and
pH-independent dissociation constants and pKa is the average
proton dissociation constant for the sidechains of the three His
residues, taken to be close to 6.5.28 Note that eqn (3) and (4)
address protonation equilibria of only those His sidechains that
are involved in Cu(I) binding and assume negligible influence
from other residues not involved directly in the binding to Cu(I).
The experiments were conducted within the pH range 5.5–7.8 in
buffers MES (pKa = 6.1) and MOPS (pKa = 7.2) employing
[CuI(Fs)2]
3 as a chromophoric probe. The pH of each solution
after an experiment was confirmed with a pH micro-electrode to
ensure recording of an accurate value for each solution. The K I
0
D
values within this pH range were derived by curve-fitting of the
experimental data to eqn (2), taking advantage of the low pKa value
of B3.2 for the probe ligand Fs. This means that the formation
constant b2 of [Cu
I(Fs)2]
3 is essentially pH-independent at pH >
5.5.26 This latter property was confirmed by determination of an
essentially identical K ID, within experimental error, for control Cu(I)
complexes of protein CopK and its variant H70F following the same
approach, again using [CuI(Fs)2]
3 as the determining probe (see
Table S1, ESI†). The Cu(I) sites in both CopK proteins are defined by
four methionine sidechains arranged tetrahedrally and so their
Cu(I) binding affinities are expected to be pH-independent.27
Quantification of Cu(II) binding via direct metal ion titration
Direct titration of Cu2+ into a solution of peptide P may induce
reaction (5) where the fraction of bound Cu(II) is described by
eqn (6):
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Cuaq
2+ + 2P + ‘CuII–B’" 2CuII–P + B (5)
CuIIP 
½CuðIIÞtot
¼ ½P
K IID 1þ KA½Bð Þ þ ½P
(6)
K IID is the dissociation constant of Cu
II–P and KA is the
average association constant of the putative complex(es) CuII–B
(B = buffer and all other potential Cu(II) ligands except H2O).
A pre-condition for a meaningful quantitative analysis via
eqn (6) is that K IID(1 + KA[B]) B [P]. To assist such analysis, an
Ab16 variant Ab16wwa was designed and synthesised. Phe4 and
Tyr10 were each replaced with Trp and His14 was replaced with
Ala. Upon excitation at 280 nm, the fluorescence emitted by
Ab16wwa at 360 nm was at least 100-fold more intense than
that by Ab16. Binding of paramagnetic Cu(II) to Ab16wwa
quenched this intense fluorescence sensitively. Consequently,
the experimental concentration of P = Ab16wwa could be varied
significantly to allow a possible detection of the equilibrium of
eqn (5). This, in turn, allowed analysis under the conditions
imposed by eqn (6). To minimise potential interference of
putative CuII–B complex(es) in eqn (5), the titration was con-
ducted in a minimal concentration of MOPS or HEPES buffers,
both of which exhibit a low affinity for Cu(II).
Quantification of Cu(II) binding via ligand competition
Reliable estimation of Cu(II) aﬃnity by direct metal ion titration is
restricted by the pre-condition K IID(1 + KA[B])B [P] of eqn (6) and is
subject to further uncertainties associated with the putative term
KA[B] that cannot be evaluated reliably for most proton buﬀers. To
lift the restriction (diﬃcult to satisfy for K IID values much less than
the experimental [P]) and to suppress the uncertainties, the Cu(II)
buﬀer glycine (Gly; KA1 = 1.17 106 M1 and KA2 = 6.76 104 M1
at pH 7.4)12,30 was used to control the Cu(II) speciation (eqn (7)
and (8)). Data was processed according to eqn (9) and (10):12
[CuII(Gly)+] + [CuII(Gly)2] + 2P" 2Cu
II–P + 3Gly (7)
[Cu(II)]tot = [Cu
II(Gly)+] + [CuII(Gly)2] + [Cu
II–P] (8)
Cuaq
2þ  ¼ ½CuðIIÞtot  CuIIP
 
KA1½Gly þ KA1KA2½Gly2
(9)
CuIIP 
½Ptot
¼ Cuaq
2þ 
KIID þ Cuaq2þ
  (10)
where the term [Gly] in eqn (9) is the free Gly concentration at
equilibrium in eqn (7) and its calculation was detailed in
ref. 12. Note that Gly is a neutral zwitterion in solution at pH
7.4 but is uni-negative when bound as a ligand to CuII. For
simplicity, these protonation states are not reflected in the nota-
tion of eqn (7)–(9). A pre-condition for eqn (7) and (8) is that the
contributions of both Cuaq
2+ and the putative ‘CuII–B’ complexes
to the total Cu(II) speciation are small enough to be ignored. Then
[Cuaq
2+] may be estimated from eqn (9) based on known forma-
tion constants KA1 and KA2 at pH 7.4 and K
II
D for Cu
II–P be derived
from curve-fitting to eqn (10) of the variation of [Cuaq
2+] as a
function of Gly addition (with consequent variation of [CuII–P]).
This approach was applied to determine K IID for the probe
Ab16wwa via quenching of its intense fluorescence upon Cu(II)
binding. Typically, a series of solutions in MOPS buﬀer (10 mM,
pH 7.4) were prepared that contained Ab16wwa (2.0 mM), Cu(II)
(1.6 mM; 0.8 equiv.) and increasing concentrations of Gly. The
fluorescence intensities at 360 nm (F) of the solutions increased
with increasing concentrations of Gly and reached a constant
value (Fo) that was >95% that of a control containing Ab16wwa
(2.0 mM) only (see Fig. 6a below). The behaviour indicated that
addition of Gly induced the reverse reaction of eqn (7) and that
there is little inner filter eﬀect under the conditions of low
Cu(II) concentration. Consequently, [CuII–P] = [CuII–Ab16wwa]
may be estimated from eqn (11) and then [Cuaq
2+] and KD from
eqn (9) and (10):
CuIIP 
½Ptot
¼ F0  F
F0  F0:8  0:8 (11)
An additional estimate of K IID for Ab16wwa was made by
application of an independent Cu(II) competing ligand nitrilo-
triacetic acid (NTA). The details are given in the ESI† and
Fig. S3.
Quantification of Cu(II)-binding to selected Ab16 peptides with
probe Ab16wwa
The Cu(II) aﬃnities of Ab16 and its variants were determined
conveniently based on competition for Cu(II) with the probe
peptide Ab16wwa:
Ab16 + CuII–Ab16wwa" CuII–Ab16 + Ab16wwa (12)
Kex ¼
CuIIAb16 ½Ab16wwa
½Ab16 CuIIAb16wwa  ¼ K
II
DðAb16wwaÞ
K IIDðAb16Þ
(13)
At molar ratios Ab16 : Ab16wwa o 3, the fluorescence
intensity at 360 nm is dominated by that of Ab16wwa with
negligible contribution from Ab16 (see Fig. 5a below).
Consequently, the term [CuII–P] = CuII–Ab16 may be obtained
from eqn (11) and then all other terms in eqn (12) from a mass
balance at each known total concentration. This allows defini-
tion of K IID for Ab16 relative to that of Ab16wwa according to
eqn (13).
The experiments were conducted as two types of comple-
mentary titrations. In the first, fluorescence intensity was
quenched by titration of aliquots of CuSO4 (10 mL, 80 mM) into
a 2.0 mL solution in MOPS (10 mM, pH 7.4) containing either
Ab16wwa (2.0 mM) alone or both Ab16wwa and the target
peptide (each 2.0 mM). In the second, fluorescence intensity
was recovered by titration of aliquots of the target peptide
(4.0 mL, 500 mM) into a 2.0 mL solution in MOPS (10 mM,
pH 7.4) containing Ab16wwa (2.0 mM) and Cu(II) (1.6 mM). The
Cu(II) speciation was analysed via eqn (11) in both cases.
Catalytic aerobic oxidation of ascorbate and generation of H2O2
Generation of H2O2 by catalytic aerobic oxidation of Asc
was monitored by UV-Vis spectroscopy via an assay based
upon the dye Amplex Red31 using an experimental procedure
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described recently.32 The solution conditions for a typical
reaction were: [Asc]tot B 50 mM, [Amplex Red]tot B 45 mM;
[HRP]B 0.35 U mL1; [Cu]tot = 5.0 mM (if added) and [ligand]tot =
7.0 mM. The reactions were started by addition of Asc into a
solution containing all other components in air-saturated MOPS
buﬀer (50 mM, pH 7.4). Spectral changes were recorded at intervals
of 50 s. A control solution without Asc served for baseline correc-
tion. The initial absorbance observed at 265 nmwas sensitive to the
reaction rate and solution composition. Use of Cuaq
2+ as catalyst led
to considerably lower initial absorbance than the other test solu-
tions due to its higher relative reaction rate.
The apparent reduction potentials of the copper centres in
various Cu–Ab16 complexes were estimated from the relative
affinities of the peptides for Cu(I) and Cu(II) via the Nernst
relationship of eqn (14):
Eo
0 ðmVÞ ¼ Eo þ 59 log KD Cu
II
 
KDðCuIÞ
 !
(14)
where Eo = 153 mV (vs. SHE) is the standard reduction potential
of Cu2+/Cu+.33
Results and discussion
Ab16 binds Cu(I) with sub-nanomolar aﬃnity
The chromogenic ligands Fs (Fig. 1a, inset) and Fz have been
developed as quantitative probes for weaker Cu(I) binding.26
When in excess, both react quantitatively to yield well-defined
complex anions [CuI(Fs)2]
3 (lmax = 484 nm; e = 6700 cm
1 M1;
b2 = 10
13.7 M2) and [CuI(Fz)2]
3 (lmax = 470 nm, e = 4320 cm
1
M1; b2 = 10
15.1 M2). This enables them to buﬀer free Cuaq
+
concentrations (expressed hereafter as pCu+ = log[Cuaq+]) in
the respective ranges pCu+ = 8–12 and 10–14. However, the
complexes are air-sensitive and subject to substitution by other
weak Cu(I) ligands, especially for [CuI(Fs)2]
3. Consequently, all
reactions must be performed under anaerobic conditions in
MOPS buffer containing reductants NH2OH and/or Asc with
exclusion of all other potential Cu(I) ligands such as Cl.26
A probe solution of [Cu]tot = 30 mM with a minimum molar
ratio of Fs/Cu B 2.3 (to ensure the dominance of [CuI(Fs)2]
3)
was necessary to observe quantitative transfer of Cu(I) from
[CuI(Fs)2]
3 to the Ab16 peptide (i.e., eqn (1) goes to comple-
tion; see Experimental section). The peptide has a relatively
weak aﬃnity for Cu(I) and, even in this solution buﬀered at
pCu+ B 8.2, it is only able to extract Cu(I) from [CuI(Fs)2]
3
quantitatively for Ab16/Cu o 0.4 (Fig. 1a and b). Linear extra-
polation of the data at low Ab16/Cu ratios demonstrates that
Ab16 possesses a single site of highest aﬃnity for Cu(I).
Increasing [Fs]tot to 180 mM under otherwise identical con-
ditions constrained the free Cuaq
+ concentration to pCu+ B
10.3 and imposed an eﬀective competition for Cu(I) according
to eqn (1) (Fig. 1c). Dilution of each equilibrium solution
resulted in partial transfer of Cu(I) from the complex to the
peptide to reach a new equilibrium position, as shown by
comparison with the dotted traces in (ii) of Fig. 1b and c,
derived from simple 1 : 1 dilution of data sets (i). Eqn (2) (which
assumes a single binding site) was used to fit the four sets of
independent experimental data. This process allowed extrac-
tion of the equilibrium constant Kex = b2  K ID and estimation
of K ID = 10
10.4 M at pH 7.4. The estimate was the same for each
data set, within experimental error.
Ligand Fz has a higher aﬃnity for Cu(I) and, even at the
minimum allowable molar ratio of Fz/Cu B 2.3, imposed an
eﬀective competition for Cu(I) between Fz and Ab16. This
allowed estimation of an indistinguishable K ID = 10
10.4 M at
pH 7.4. This work substantiates preliminary results reported
previously,26 but contrasts considerably the other two earlier
values (K ID B 10
7 M15 and 1015 M14). The present value was
determined relative to b2 = 10
15.1 M2 for [CuI(Fz)2]
3 which, in
turn, was derived based on b2 = 10
17.2 M2 for [CuI(Bca)2]
3
(Bca: bicinchoninic anion).26,34 The latter value was consoli-
dated recently by an independent study.35,36
Fig. 1 Quantification of Cu(I) binding to the Ab16 peptide in buﬀer A. (a) Changes in absorbance of [CuI(Fs)2]
3 solution ([Cu]tot = 30 mM; [Fs]tot = 70 mM)
with increasing concentration of Ab16 peptide. The structure of the Fs ligand is shown in the inset; (b, c) variation of concentration of [CuI(Fs)2]
3 with
increasing molar ratio Ab16 : Cu in Cuaq
+ buﬀer of initial p[Cu+] = 8.2 ([Cu]tot = 30 mM; [Fs]tot = 70 mM) in (b) and initial p[Cu
+] = 10.3 ([Cu]tot = 31 mM;
[Fs]tot = 180 mM) in (c). The experimental data in solid circles were derived from the solutions prepared as described in the Experimental section. The data
in empty circles was obtained after 1 : 1 dilution of the original solutions with proton buﬀer A. The two solid traces in (i, ii) are the fitting of the experimental
data to eqn (2). The dotted traces in (ii) are the simple 1 : 1 dilutions of the data set (i). The two dashed lines intercepting Ab16 :Cu = 1.0 in (b) allowed
estimation of the binding stoichiometry.
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At least two His are involved in Cu(I) binding to Ab16 but the
N-terminal amine is not
Spectroscopic examination has implicated the His sidechains
of the Ab16 peptide DAEFRHDSGYEVHHQK as Cu(I) ligands.21,23–25
The N-terminal amine and carboxylate sidechains may also be
involved.
The aﬃnities of a number of variants of Ab16 were investigated
with probe Fs (Fig. 2 and Table 1). Probe Fz is less satisfactory in
these systems as its aﬃnity for Cu(I) is too high to allow eﬀective
competition. Substitution of any one of the three His residues with
non-binding Ala reduced the aﬃnities of the resultant peptides
H6A, H13A and H14A by factors of between two and five. Removal
of two His residues decreased the aﬃnity of H6,13A and H13,14A
by factors of >50 and >250, respectively. On the other hand,
acetylation of the N-terminus (Ac-Ab16) did not alter the aﬃnity
of the peptide for Cu(I). The Cu(I) aﬃnity of the triple mutant
probe peptide F4W,Y10W,H14A (i.e., Ab16wwa) is indistinguish-
able from that of the single mutant H14A (Table 1).
These experiments demonstrate that (i) at least two His side-
chains are required for eﬀective binding of Cu(I) but that all three
His ligands contribute significantly; (ii) the N-terminal amine is
not a Cu(I) ligand; (iii) substitution of residues not involved directly
in Cu(I) binding (e.g., aromatics F4,Y10) has little impact on the
aﬃnity, consistent with the structural flexibility of the peptide.
Variation of K ID with pH suggests that only two of the three His
residues of Ab16 are involved simultaneously in Cu(I) binding
The sensitivity of the derived K ID values to the availability of
the three His residues suggested that this parameter may be
pH-dependent. His sidechains exhibit characteristic pKa values
of 6.0–6.5 and an average pKa value of the three His sidechains
in an Ab28 peptide was estimated to be 6.53.28 Consequently, at
pH o 7, protons may compete with Cu(I) for these sidechains.
K ID for Ab16 is sensitive to pH (black circles; Fig. 3a). With both
K ID and pKa as fitting parameters, the experimental data were
fitted satisfactorily to eqn (3) assuming the availability of two His
ligands only (black trace). Fitting to a model that assumes the
availability of all three His ligands (eqn (4)) was less adequate (red
dotted trace; Table 1). The essential diﬀerence is that the average
pKa = 6.5 derived from the two-His model is the same as that
determined independently by NMR28 while the value of 6.1
derived from the three-His model is significantly smaller
(Table 1). However, when the parameter pKa was constrained to
the experimental value 6.5 so that K ID was the only fitting para-
meter, the curve fitting remained optimal for the two-His model
but was unsatisfactory for the three-His model (Fig. 3a: black trace
versus green dotted trace; Table 1).
Further support for the two-His model is provided by the
equivalent experiments for the three Ab16 variants H6A, H13A
and H14A (Fig. 3b(iii)–(v)). Their KID values are also pH sensitive
and the relationship in each case was described satisfactorily by the
two-His model (eqn (3)) with both K ID and pKa values derived from
the curve-fitting matching those experimental values (Fig. 2 and
Table 1). Each variant peptide features two His residues only and so
can contribute a maximum of two His sidechains for Cu(I) binding.
The equivalent experiment for Ac-Ab16 (acetylated at the
N-terminus) generated similar results to those for Ab16 itself
Fig. 2 Variation of Cu(I) binding aﬃnity of the Ab16 peptide upon mod-
ification of individual peptide residues. Probe composition: [Cu]totB 31.4 mM
and [Fs]tot = 140 mM in proton buﬀer A. Within experimental error, pairs
(Ab16-wt; Ac-Ab16) and (H6A; H14A) provided indistinguishable data.
Table 1 Log KID and pKa for the Ab16 peptide and selected variants
a
Peptide
LogKID
b
KID/K
I
D(wt) pKa from curve fitting Fitting R factor Fitting curve in Fig. 3Direct det. at pH 7.4 From fitting pH variation
Ab16 10.4 10.5 1.0 6.5 0.99 Black trace i
10.4c 6.1c 0.97c Red dotsc
10.8d 6.5 (fixed)d 0.83d Green dots
Ac-Ab16 10.4 10.5 1.0 6.6 0.97 ii
H6A 10.0 10.1 2.5 6.5 0.99 iii
H14A 9.95 9.95 2.8 6.6 0.98 iv
Ab16wwa 9.98 — 2.6 — — —
H13A 9.76 9.84 4.4 6.6 0.99 v
H6,13A 48e 4250
H13,14A 48.7e 450
a Unless otherwise indicated, the listed parameters were derived from curve-fitting of the experimental data to eqn (3) based on a CuI(His)2 site
model with both KID and pKa as fitting parameters.
b Estimated experimental errors 0.05 unless indicated otherwise. c From curve-fitting to
eqn (4) based on a CuI(His)3 site model with both K
I
D and pKa as fitting parameters.
d From curve-fitting to eqn (4) (a CuI(His)3 site model) with
pKa = 6.5 fixed and K
I
D as the only fitting parameter.
e Approximate estimates only at the detection limit of Fs probe with large uncertainty.
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(Fig. 3b, (i) vs. (ii); Table 1), although the former carries one less
positive charge than does the native peptide. This supports the
condition set previously for derivation of pH dependence via
eqn (3) and (4): protonation of other non-metal-binding sites
has minimal impact on the observed K ID. It also re-aﬃrms that
the N-terminus is not involved in Cu(I) binding.
Taken together, these experiments provide strong evidence
that the Cu(I) site in Ab16 includes two only of the three
available His ligands. This conclusion is supported by X-ray
absorption spectroscopy and theory.21,23,24,37 On the other
hand, the data of Fig. 2 and 3 and Table 1 demonstrate that
replacement of any one of the three His residues in Ab16 led to
a marginal decrease only in Cu(I) binding aﬃnity (i.e., any two
will do) but that replacement of any two His ligands disabled
the binding site. When combined with the NMR study,21 the
data are consistent with the presence of solution dynamic
processes that exchange Cu(I) between the three available pairs
of His ligands (Fig. 4). This dynamic nature proves to be
important for redox cycling in the catalytic production of
H2O2 (vide infra).
Development of a highly fluorescent peptide probe for
estimation of Cu(II) aﬃnities
The well-characterised Cu(II) ligand Gly has been used as an
aﬃnity standard to determine the Cu(II) aﬃnities of Ab peptides.
Spectroscopic approaches have relied on the fluorescence emis-
sion of the single Tyr residue in Ab peptides as the detection
probe. However, both detection sensitivity and specificity are
compromised by the relatively weak emission intensity of Tyr
and interference from secondary Cu(II) binding sites.13
A probe based upon the Ab peptide was designed by replace-
ment of aromatic residues Phe4 and Tyr10 with Trp to increase
detection sensitivity and of His14 by Ala to suppress secondary
Cu(II) binding. The resultant peptide Ab16wwa exhibited excel-
lent properties as a probe for quantification of Cu(II) binding to
other Ab peptides: (i) it binds either Cu(I) or Cu(II) with aﬃnities
indistinguishable from those of H14A (see Tables 1 and 2); (ii) it
emits fluorescence (lex, 280 nm; lem 360 nm) that is an order of
magnitude more intense than that of the Ab16 peptide at
310 nm or more than two orders of magnitude more intense
than that at 360 nm (Fig. 5a); (iii) at a concentration of 20 mM, it
responds sensitively to Cu(II) binding with a distinct turning
point at one equivalent of Cu(II) with evidence of further binding
to a second equivalent (Fig. 5b, blue trace). In contrast, the
response of Ab16 to Cu(II) binding is much less sensitive and
poorly defined with up to three equivalents of Cu(II) binding
detectable under the same conditions (Fig. 5b, red trace).13
Quantification of Cu(II) binding to Ab16wwa probe
Addition of bis(2-hydroxyethyl)amino-tris(hydroxymethyl)-methane
(BisTris) (1.0 mM) into the MOPS buﬀer (50 mM; pH 7.4) for the
Cu2+ titration eliminated Cu(II) binding to the weaker site in
Ab16wwa (20 mM; Fig. S1, ESI†) and induced competition between
BisTris and the stronger peptide binding site for Cu(II) according to
eqn (5) (P = Ab16wwa; B = BisTris; KD = 10
5.2 M1 for CuII-BisTris
at pH 7.438 while MOPS has little Cu(II) aﬃnity). After addition of
one equivalent of Cu(II), >90% of total added Cu(II) was bound by
the peptide. Consequently, an aﬃnity of K IID o 109 M may be
Fig. 3 Variation of pKID (=logKID) with solution pH: (a) comparison of
curve-fittings of the experimental data for Ab16-wt to eqn (3) (black solid
trace) or eqn (4) (red dotted trace) or to eqn (4) with fixed input of pKa = 6.5
(green dotted trace); (b) curve-fittings of the experimental data to eqn (3)
for: (i) Ab16 (black dots & trace); (ii) Ac-Ab16 (purple crosses & trace); (iii)
H6A (red dots & trace); (iv) H14A (green dots & trace); (v) H13A (blue dots &
trace). The fitting parameters in each case are given in Table 1.
Fig. 4 Model of Cu(I) binding in Ab16 peptide derived from the experi-
mental data in Fig. 2 and 3.
Table 2 Selected logKIID for Cu
II–Ab complexes estimated via ligand
competitiona
Peptide LogKIID Aﬃnity std. Det. probe Ref.
Ab16wwa 9.8 Gly Ab16wwa This work
9.8 NTA Ab16wwa This work
Ab16 10.0 Gly Ab16wwa This work
Ab16 10.0 Gly Tyr in Ab 13
Ab28 10.0b Gly Tyr in Ab 11
Ab42 10.2 Gly Tyr in Ab 11
Ab16/40 9.6 Gly ITC 41
Ab16 9.0c ACES ITC 42
Ab28 8.8c ACES ITC 42
a Refer to ref. 13 for a summary of more extensive literature values
estimated via various approaches. b Estimated at pH 7.6. c Estimated
using N-(2-acetamido)-2-aminoethanesulfonic acid (ACES) as both pro-
ton buﬀer and Cu(II) aﬃnity standard.
Paper Metallomics
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
4 
Ja
nu
ar
y 
20
14
. D
ow
nl
oa
de
d 
on
 2
1/
05
/2
01
8 
11
:4
8:
24
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Online
This journal is©The Royal Society of Chemistry 2014 Metallomics, 2014, 6, 505--517 | 511
estimated from eqn (6) based on the above KD for Cu
II-BisTris.38
On the other hand, the high emission intensity of the Ab16wwa
probe allows its experimental concentration to be reduced signifi-
cantly. At concentrations between 0.2 and 2.0 mM,39 Cu(II) binding
to the weaker site was suppressed while that to the stronger site
remained dominant (Fig. 5c). Even at the lowest peptide concen-
tration of 0.20 mM,Z94% of total added Cu(II) was estimated to be
bound by the peptide after addition of one equivalent of Cu(II)
titration. Consequently, an aﬃnity of K IID r 109.1 M may be
estimated from eqn (6) without consideration of the possible
contribution of Cu(II) binding to the MOPS buﬀer at 1.0 mM.
However, in either case, the degree of complex formation was too
high (>90%) to allow a reliable estimation of K IID.
40
These experiments demonstrate that: (i) the second binding
site for Cu(II) in Ab16wwa is relatively weak (K IID Z 10
6 M); (ii)
direct metal ion titration defines the binding stoichiometry of
Cu(II) : Ab16wwa = 1.0 for the stronger site but can provide an
approximate value only for the binding aﬃnity: K IIDr 109.1 M
at its lowest experimental concentration of 0.2 mM. The detec-
tion sensitivity for the parent Ab16 peptide is lower by a factor
ofB100, thereby setting estimation limit of its aﬃnity to K IIDo
107 M with high uncertainty. This provides an answer to the
puzzle of why the Cu(II) aﬃnities acquired in the past for Ab
peptides via direct metal ion titration were scattered so widely
around K IID B 10
7 M.11,13,20
It is apparent that the Cu(II) aﬃnity of the Ab16wwa probe is
too high (i.e., K IID is too small) to be determined by direct metal
ion titration and a ligand competition approach is required for
reliable estimation.12 Glycine (Gly) and nitrilotriacetic acid
(NTA) are two suitable competing ligands. Experimental results
with Gly are described below and those with NTA are given in
the ESI† and Fig. S3.
Gly binds Cu(II) to yield 1 : 1 and 1 : 2 complexes with
formation constants KA1 = 10
6.07 and KA2 = 10
4.77 M1 at
pH 7.4.43 The fluorescence intensity of an Ab16wwa solution
(2.0 mM) in MOPS buﬀer (10 mM, pH 7.4) was quenched
markedly by addition of Cu2+ (0.80 equiv.) but was recovered
almost quantitatively (>95%) by titration of a large excess of
Gly (>10 mM; Fig. 6a). This demonstrates that: (i) Cu(II) bound
to the peptide can be removed reversibly; (ii) Gly imposes
no discernable inner-filter eﬀect; (iii) the inner-filter eﬀect
of CuII–Gly complex(es) at low concentrations (r1.6 mM)
is negligible. Consequently, at each point of the titration,
the occupancy [CuII–P]/[P]tot can be estimated via eqn (11)
and the corresponding free Cuaq
2+ concentration analysed
via eqn (7)–(9). Curve-fitting to eqn (10) led to KD = 10
9.8 M
at pH 7.4 for CuII–Ab16wwa. This data is supported by equiva-
lent and independent experiment with NTA as a competing
ligand that provided the same K IID = 10
9.8 M at pH 7.4 within
the experimental error (see Table 2 and Fig. S3, ESI†).
Fig. 5 Comparison of Ab16 peptides (20 mM) in MOPS (50 mM, pH 7.4): (a) fluorescence spectra of Ab16wt (green trace), Ab16wwa (blue trace) and their
diﬀerence (pink trace) under the same conditions; (b) plot of normalised fluorescence (F/Fo) versus Cu(II) : Ab16 ratio for Ab16wwa (blue) and Ab16wt (red);
(c) same plot as (b) but for Ab16wwa at 2.0 mM (purple) and 0.20 mM (cyan) in MOPS (1.0 mM, pH 7.4).
Fig. 6 Determination of Cu(II) aﬃnity of Ab16wwa in MOPS buﬀer (10 mM, pH 7.4): (a) fluorescence spectra of Ab16wwa (2.0 mM; blue trace); Ab16wwa
(2.0 mM) plus Cu(II) (1.6 mM) (green trace); Ab16wwa (2.0 mM) plus Cu(II) (1.6 mM) plus Z 10 mM Gly (red trace); (b) recovery of fluorescence intensity for
CuII0.8–Ab16wwa (2.0 mM) with increasing Gly concentration; (c) curve fitting of [Cu
II–P]/[P]tot versus log[Cuaq
2+] to eqn (10) derived an estimate of
KIID = 10
9.8 M for CuII–Ab16wwa.
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Estimation of the aﬃnities of Ab16 peptides for Cu(II) using the
Ab16wwa probe
As the aﬃnity of the probe peptide Ab16wwa for Cu(II) is
comparable to those of many other Ab peptides, two comple-
mentary approaches based on eqn (12) and (13) were employed:
(i) monitoring of fluorescence quenching by direct titration of
Cuaq
2+ into a solution containing Ab16wwa and the target
peptide in equimolar concentrations (2.0 mM) relative to a
control that contained Ab16wwa only (Fig. S4, ESI†); (ii) mon-
itoring the fluorescence recovery of the probe by titration of the
target peptide into a solution containing Ab16wwa (2.0 mM) and
0.8 equiv. of Cu(II) (1.6 mM) (Fig. 7a and b). The Cu(II) speciation
in eqn (12) and (13) may be analysed reliably via eqn (11) as
the fluorescence intensity of the probe at 360 nm is more than
100 fold greater than those Ab peptides that contain a single Tyr
residue only (Fig. 5a, Fig. S5a, ESI†). Approach (ii) may be
compromised in cases where a large excess of target peptide is
required to impose competition. Then, despite their low extinction
coeﬃcient around the excitation position (e276 1410 M
1 cm1)
and low emission intensity at the detection position (360 nm), the
target peptides may still impact on the observed fluorescence
intensity when in large excess (Fig. S5b, ESI†). This follows from
a combination of inner-filter and fluorescence eﬀects of the target
peptides. However, in the present systems, the impact was negli-
gible when the target peptide was restricted to no more than two
equivalents relative to Ab16wwa (Fig. 5a, Fig. S5a, ESI†).
At pH 7.4, both approaches estimated K IID = 10
10.0 M for
Ab16 based on K IID = 10
9.8 M for Ab16wwa. This value is in an
excellent agreement with the recent consensus value of KD B
1010 M (Table 2).11,13 Substitution of any one of the three His
residues by Ala decreased the aﬃnity for Cu(II) marginally
(by 2–3 fold; Fig. 7a and b, Fig. S4, ESI;† Table 3). In addition,
K IID values for H14A and Ab16wwa were the same within
experimental error, confirming that removal of the aromatic
residues has little impact on the copper binding chemistry. It
appears that, as for the case of Cu(I), any two of the three His
ligands can contribute to binding of Cu(II) and that a dynamic
exchange equilibrium is present. However, the K IID value of
H13,14A is identical to that of H6A but is three-fold smaller
than that of H6,13A (Table 3). This is consistent with His6
playing a more important role than either His13 or His14 in
Cu(II) binding. These observations are in agreement with a
current Cu(II) binding model that suggests that His6 is an
essential equatorial ligand while a second equatorial ligand is
provided interchangeably by either His13 or His14 (Fig. 8).8 On
the other hand, acetylation of the N-terminal nitrogen leads to a
dramatic decrease of affinity by more than an order of magni-
tude (Fig. 7a and b, Fig. S4, ESI;† Table 3), demonstrating that
the N-terminal nitrogen is another key Cu(II) ligand (Fig. 8).
These data support previous analysis of relative affinities,11,42
but provide a sensitive and reliable basis for detection of these
differences experimentally (Table 3).
Analysis of the relative aﬃnities for Cu(II) in CHES ((cyclo-
hexylamino)ethanesulfonic acid) buﬀer at pH 9.0 provides a
somewhat diﬀerent story (Fig. 7b). Overall, His ligands and the
N-terminal nitrogen appear to make lesser contributions to the
Cu(II) binding than those at pH 7.4 although the influence of
His6 remains unchanged (Fig. 7 and Table 3). This suggests
that increasing pH promotes deprotonation of the Ala2 back-
bone amide for Cu(II) coordination and formation of the
so-called component II (Fig. 8).8 Consistent with this model,
variant peptides H13A, H14A and H13,14A all display aﬃnities
for CuII that are only marginally weaker than that of the wild-
type peptide (Fig. 7b and Table 3). It appears that neither
His13 nor His14 are crucial ligands in component II. In
contrast, both H6A and H6,13A variants show a significant
reduction in aﬃnity (Fig. 7b and Table 3). Current models
require only one His ligand for component II,8 and our data
suggests that the identity of this ligand is His6 – perhaps due
to its proximity to the N-terminal chelate ring. The significant
loss of affinity upon acetylation indicates that the N-terminal
nitrogen remains as an essential Cu(II) ligand at this pH. Thus
the observed changes in the relative affinities of Ab16 variants
at pH 9.0 (Table 3) supports the proposed change in coordina-
tion environment in component II (Fig. 8), as observed by a
variety of spectroscopic techniques44 including EPR, CD and
NMR.16,45
Fig. 7 Determination and comparison of Cu(II) dissociation constants for
Ab16 peptides using Ab16wwa as a probe at pH 7.4 (a) and 9.0 (b): (i)
Ab16wt; (ii) H14A or H13A; (iii) H6A; (iv) H13,14A; (v) H6,13A; (vi) Ac-Ab16. All
experiments were conducted by titration of target peptide (4.0 mL, 500 mM)
into a solution (2.0 mL) containing Ab16wwa (2.0 mM) and Cu(II) (1.6 mM) in
either MOPS buﬀer (10 mM, pH 7.4) or CHES buﬀer (10 mM, pH 9.0). The
complete set of derived KIID values is given in Table 3.
Table 3 Cu(II) aﬃnities of Ab16/28 peptides relative to those of the wild
type forms
Ab16
LogKIID K
II
D/K
II
D(wt)
Ab28
KIID/K
II
D(wt)
pH 7.4 pH 7.4 pH 9.0 pH 7.4a pH 7.8
wt 10.0 1.0 1.0 wt 1.0 1.0
Ac-Ab16 8.3 50 10 Ac-Ab28 10.6 7.9
H6A 9.5 3.2 3.2 H6A 1.3 2.5
H13A 9.7 2.0 1.6 H13A 0.8 1.3
H14A 9.7 2.0 1.3 H14A 0.9 1.3
Ab16wwa 9.8 1.6 — — —
H6,13A 9.0 10 3.2 — —
H13,14A 9.5 3.2 1.6 — —
Ref. This work This work This work 42 11
a Estimated using N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)
as both proton buﬀer (20 mM, pH 7.4) and Cu(II) aﬃnity standard and
ITC as detection probe.
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Catalytic aerobic oxidation of ascorbate and generation of H2O2
A common feature in Alzheimer’s disease is oxidative stress
caused by reactive oxygen species (ROS). It has been proposed
that one source is undesirable redox chemistry imposed by Cu
bound to the disease proteins/peptides including, most impor-
tantly, the Ab peptides.46 Ascorbic acid is an abundant physio-
logical reductant in the central nerve system (CNS) and is
important as a neuromodulator and/or neuroprotective agent
in the brain.47,48 Its oxidation by dioxygen can produce H2O2
that, if uncontrolled, may undergo further reduction viaHaber–
Weiss and related reactions to generate the hydroxyl radical
OH, a likely source of oxidative stress and inflammation.49
However, the oxidation is intrinsically slow and must be
catalysed by redox-active couples such as CuII/CuI. The Cu ion
bound in Ab peptides has been demonstrated capable of
assuming such a catalytic role.32,50 The present work has
characterised the thermodynamic properties of a range of Cu
centres in selected Ab16 peptides and, in particular, compared
their relative Cu(I) and Cu(II) binding affinities reliably under
the same conditions. This provides an unprecedented oppor-
tunity for an integrated study to correlate these thermodynamic
properties with their efficiencies for generation of H2O2 via
catalytic aerobic oxidation of Asc.
The catalytic reaction was followed by UV-visible spectro-
scopy (Fig. 9).31 While the ‘free Cuaq
2+ ion’ is a robust catalyst,
the redox-inactive complex [CuII(EDTA)]2 was not (Fig. 9b and
c(i) vs. (vii)). All metal-free Ab16 peptides were catalytically
inactive. As observed previously,32,50 binding of ‘free Cuaq
2+
ion’ by Ab16 diminishes but does not silence the catalytic
activity of the Cu centre (Fig. 9b and c(v); Table 4). Overall,
the catalytic activity decreases in the following order of ligand
environments (relative to that for Ab16-wt taken as unity):
H2O (>4) > H6,13A B H13,14A (2.8) > H13A B H14A (1.5)
> wt (1.0) > H6A (0.8) > Ac-Ab16 (0.3) > EDTA (0)
(15)
Aerobic oxidation of ascorbate may be represented by two
redox half-reactions: two-electron oxidation of Asc to dehydro-
ascorbate (D-Asc) coupled to two-electron reduction of O2 to
H2O2 (Fig. 10). Their respective reduction potentials at pH 7.0
are about +50 mV51 and +300 mV52 and hence the oxidation is a
thermodynamically favored process. However, the reaction is
very slow without a catalyst and the catalytic activity of a Cu
centre depends on the eﬃciency of redox cycling between its
CuI and CuII forms. This, in turn, is determined by both
thermodynamic and kinetic factors. The molecular basis of
the order of catalytic activity defined by eqn (15) may be
analysed with regard to both factors.
Thermodynamically, the reduction potential of a favoured
catalyst must fall within the range +50 and +300 mV. ‘Free Cu2+
ion’ is a robust catalyst likely due to its reduction potential
(+153 mV vs. SHE) falling about midway in this range and the
presence of exchangeable aqua ligands only. The formal
reduction potential of a copper centre is linked via the Nernst
equation (eqn (14)) to the relative binding aﬃnities of the
diﬀerent oxidation states. Both Cu(I) and Cu(II) aﬃnities in
selected Ab16 peptides have been determined at the same pH =
7.4 in this work and are listed in Table 4. The calculated
reduction potential for the copper centre in Ab16 (Eo0 =
+178 mV) closely matches an experimental value (E1/2 =
+180 mV)21 determined by direct electrochemistry and predicts
Fig. 8 Equilibrium of Cu(II) binding modes in solution (pKaB 7.8) without
considering possible axial coordination.8
Fig. 9 Catalytic aerobic oxidation of Asc and production of H2O2. (a) UV-Vis monitoring of Asc consumption and resorufin formation that monitors
H2O2 production. The spectrum of initial solution containing all components except Asc was subtracted from each recorded spectrum; (b) monitoring
of Asc consumption at 265 nm and (c) resorufin production at 571 nm (proportional to H2O2 production), in the presence of Cu (5.0 mM) and Cu ligand
(7.0 mM). Ligands are: (i) EDTA, (ii) Ac-Ab16; (iii) Ab16wt plus Ac-Ab16 (in 1 : 1 molar ratio); (iv) H6A; (v) Ab16wt; (vi) H13A (indistinguishable from H14A); (vii)
free Cu2+ (note: the lower end absorbance and thus less final resorufin production in (c) was due to more extensive extra consumption of Asc by the
rapidly produced Amplex Red radicals; see ref. 31). Other initial reaction conditions: [Amplex Red] = 45 mM, [HRP] = 0.35 U mL1, [Asc] = 50 mM. The
reactions were conducted in air-saturated MOPS buﬀer (20 mM, pH 7.2–7.3) and started by introduction of catalyst.
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it to be a competent catalyst. In contrast, the same calculations
based on log K ID = 715 or 1514 and the consensus log K IID =
10.0 led to estimates of Eo0 = 24 and +448 mV, respectively.
Neither predicts catalytic function. The Cu–Ab complexes,
indeed, catalyse the aerial oxidation of Asc effectively although
less actively than does Cuaq
2+. The structures of Cu(I) and Cu(II)
complexes of the Ab16 peptide are distinctly different: redox
cycling will require energy input for structural reorganisation
(Fig. 11). On the other hand, free Cu ions are under tight control
in living cells and are present in tightly-bound forms only.
Acetylation of the N-terminal nitrogen has little impact on
Cu(I) binding but removes a key Cu(II) ligand and consequently
shifts the predicted reduction potential positively to a value
(Eo0 = +277 mV) that promotes oxidation of Asc but does not
favour reduction of O2. This is consistent with the catalytic
activity of Ac-Ab16 being B30% of that of Ab16-wt (eqn (15)).
Notably, addition of Cu2+ into an equimolar mixture of Ab16
and Ac-Ab16 produced an activity that was about the average of
the combined activities of Ab16 and Ac-Ab16 (Fig. 9b and c;
compare traces (ii), (iii) and (v)). The aﬃnities of these two
peptides for Cu(I) are identical but their aﬃnities for Cu(II)
diﬀer considerably. These experiments suggest that the resting
state of the catalyst in the presence of Asc is dominated by the
Cu(I) form and that the catalytic activity of Cu-Ab16 is sup-
pressed by Ac-Ab16. These results are also consistent with the
properties of a copper centre bound to the second domain of
the amyloid precursor protein (APP-D2): it exhibits similar
aﬃnities and catalytic activities to those of the copper centre
in Ac-Ab16.32
Interestingly, APP may be processed in vivo by two enzymes,
the a/b secretases, in two diﬀerent pathways (i.e., so called non-
amyloidogenic and amyloidogenic pathways) to secrete two
soluble forms of APP N-terminal fragments, sAPPa and sAPPb.
The former cleaved site is within the Ab sequence between the
position 16 and 17 whereas the latter is located right before the
N-terminus of the Ab sequence. Consequently, while both
fragments contain Cu site in APP-D2, sAPPa diﬀers from sAPPb
by having a C-terminal 16 amino acid extension equivalent to
Ac-Ab16 in term of Cu binding sites. Our experiments suggest
that the Cu sites in APP-D2 and Ac-Ab16 may be neuroprotective
in a sense that ROS generation in the CNS by the Cu-Ab catalyst
may be suppressed partially by competitive Cu(I) binding with
APP-D2 and Ac-Ab16 (Fig. 9b and c, (iii) vs. (v)).32 Notably, it has
been reported that sAPPa shows a range of neuroprotective and
growth factor properties, including reduction of neuronal
injury and improvement in memory performance, in contrast
to the generally less potent sAPPb.53–56
Intriguingly, the predicted reduction potential for the
copper centre in each of the three single His variants H6A,
H13A and H14A is similar to that in the original Ab16 peptide.
However, mutation on His6 decreased activity by >20% while
mutation of either of the other two increased the activity by
B50%, i.e., the copper centres in the H13A and H14A copper
Table 4 Copper binding aﬃnities and relative catalytic rates of the Cu–Ab16 a
Ab16 peptide LogKID LogK
II
D E
o0
calc
b (mV) (vs. SHE)
Relative catalytic rate
Asc consumption H2O2 production
wt 10.4 10.0 +178 1.00 1.00
B7c B24e
B15d B+448e
Ac-Ab16 10.4 8.3 +277 0.37 0.34
H6A 10.0 9.5 +183 0.75 0.78
H13A 9.76 9.7 +157 1.42 1.51
H14A 9.95 9.7 +168 1.42 1.52
H6,13A 48 9.0 o+94 B2.8 B2.7
H13,14A 48.7 9.5 o+106 B2.8 B2.7
Cuaq
2+ +153 44 f 45 f
a All data were acquired in MOPS buﬀer (10–50 mM, pH 7.4). b Calculated from eqn (14) using Eo = +153 mV for the redox couple Cu2+/Cu+. c From
ref. 15. d From ref. 14. e The consensus KIID = 10
10.0 M was used for the calculation. f Reactions were too fast to estimate the initial rates reliably.
Fig. 10 Scheme for catalytic aerobic oxidation of Asc and production of H2O2.
Fig. 11 Some chemical equilibria in solution at physiological pH.
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complexes are twice as active as that in H6A (Fig. 9 and Table 4).
An electrochemical study has proposed a pre-organisation
mechanism for electron exchange between the Cu(I) and
Cu(II) forms.57 His6 is an important ligand for both Cu(I) and
Cu(II) at pH 7.4 while either His13 and His14 can contribute but
play a more important role in binding to Cu(I) than to Cu(II).
The data suggests that retention of the His6 ligand is important
for optimisation of the rate of electron exchange at pH 7.4
(Fig. 11).
Copper ions in the presence of the double His variants
(H6,13A and H13,14) exhibit higher catalytic activities (Table 4).
However, these data need to be interpreted cautiously, as the
binding aﬃnities of these variants are significantly weaker, in
particular for Cu(I) (Table 4). The observed high activities may be
related to a significant level of unbound or partially aquated Cu
under the conditions. Addition of EDTA (KD = 10
15.9 M at pH 7.4)
sequesters the copper into non-redox active CuII-EDTA that inhi-
bits the catalytic activity completely.
Summary and concluding remarks
The Ab peptides of 40–42 residues are the primary components
of the extracellular senile plaques deposited in the AD brain
and are proposed as a source of toxicity. The plaques are rich in
transition metals Cu, Zn and Fe and the toxicity may be linked
to oxidative stress induced by catalytic oxidation mediated via
redox-active metal ions and copper ions in particular. The
thermodynamic viability of a copper centre as a redox catalyst
is linked to its reduction potential that, in turn, is determined
by the relative stabilities of the two oxidation states (eqn (14)).
However, these stabilities, as measured by dissociation con-
stants KD (affinities) for Cu(I) and Cu(II) bound to Ab peptides,
have remained controversial, primarily due to a lack of reliable
detection probes and affinity standards.
All essential metal ligands in Ab peptides are located within
the first 16 residues and the fundamental Cu binding proper-
ties of Ab16 peptides have proven to be representative of those
of other longer Ab peptides. This work undertook a systematic
quantitative investigation of the Cu(I) and Cu(II) binding prop-
erties of various Ab16 peptides by employing the Fs probe
established recently for weaker Cu(I) binding26 and a new
highly fluorescent probe Ab16wwa introduced in this work
for weaker Cu(II) binding. The key results are summarised
following:
(i) Ab16 binds Cu(I) in three exchangeable two-coordinate
sites defined by two His ligands out of the total of three (Fig. 4).
The apparent binding aﬃnity is pH dependant at pHo 7.5 and
is estimated to be K ID = 10
10.4 M for wild type Ab16 at pH 7.4.
The N-terminal amine and backbone amides are not involved
in Cu(I) binding.
(ii) The N-terminal nitrogen is a key Cu(II) ligand and
appears to be part of a chelate ring ligand at pH 7.4 (Fig. 8).
All three His ligands and at least one backbone amide are
involved in Cu(II) binding but not simultaneously and only in
several dynamic exchange modes (Fig. 8). His6 appears to play a
more important role in Cu(II) binding than does either His13 or
His14. The apparent binding aﬃnity for wild type Ab16 was
estimated to be K IID = 10
10.0 M at pH 7.4, consolidating the
consensus data reported in several recent studies.
(iii) The dissociation constants K ID and K
II
D allow estimation
of the formal reduction potential for the Cu–Ab16 complex as
Eo0 = 178 mV (vs. SHE).36 This value matches E1/2 = 180 mV
determined directly by cyclic voltammetry.21 Consequently, the
complex is predicted to be a robust redox catalyst for oxidation
of Asc (B+50 mV) by dioxygen (B+300 mV) to generate H2O2
and thus other ROS. Its catalytic activity is about 25% that of
‘free Cuaq
2+’ (Eo0 = +153 mV), consistent with the distinct Cu(I)
and Cu(II) binding modes present in Ab16 and the consequent
pre-organisation energy required for the redox switching.
These new thermodynamic data consolidate the structural
interpretations for the Cu–Ab complexes deduced previously by
spectroscopic investigations and provide molecular insight into
the mechanism of ROS production by copper chemistry and of
oxidative stress in Alzheimer’s disease.
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